Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy

Recruiting Observational Study
Head and Neck Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Maastricht Radiation Oncology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary and general objective of the clinical introduction of the Standard Follow-up Program (SFP) as the current standard of care is to improve the quality of radiotherapy for head and neck cancer patients by reducing radiation-induced side effects without hampering treatment efficacy in terms of locoregional tumour control and overall survival and to systematically evaluate the beneficial ef…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: All patients planned for curatively intended primary or postoperative radiotherapy Exclusion Criteria: All patients planned for palliative radiotherapy
Contacts

F Hoebers, MD, PhD

+31884455666

frank.hoebers@maastro.nl

CONTACT